{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:58:58Z","timestamp":1785581938626,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Glioblastoma (GBM), a highly aggressive brain tumor, continues to present poor prognoses despite advancements in standard treatments. Emerging evidence identifies neurotransmitter pathways, particularly dopaminergic signaling, as significant modulators of GBM progression. This editorial examines the \u201cdopamine paradox\u201d in GBM, where D2-like receptors (D2\/D3\/D4) drive pro-tumor effects, while D1-like receptors (D1\/D5) mediate tumor suppression. Nicotine, through its activation of nicotinic acetylcholine receptors, exacerbates GBM progression by stimulating dopaminergic pro-survival pathways, particularly via D2\/D3 receptors.<\/jats:p>\n                  <jats:p>Conversely, methylxanthines such as caffeine and theophylline demonstrate potential as anti-GBM agents by modulating D1\/D5-driven cAMP pathways. These compounds inhibit phosphodiesterases, increasing intracellular cAMP levels, and mimic D1\/D5 receptor activation, leading to apoptosis, reduced proliferation, and chemosensitization. This dualistic dopaminergic signaling framework suggests therapeutic opportunities for methylxanthine repurposing to counteract nicotine-driven GBM pathogenesis.<\/jats:p>\n                  <jats:p>This editorial underscores the need for further exploration of dopaminergic modulation in GBM, highlighting the potential of shifting the balance from pro-tumor D2\/D3 signaling to antitumor D1\/D5 pathways. Understanding this paradox could pave the way for novel, low-toxicity therapeutic strategies to improve GBM outcomes.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003853","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:01:39Z","timestamp":1757970099000},"page":"6928-6930","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The dopamine paradox in glioblastoma oncology: methylxanthine therapy against nicotine-driven pathogenesis"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3425-8841","authenticated-orcid":false,"given":"Muhammad","family":"Mursaleen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6215-1857","authenticated-orcid":false,"given":"Maryum","family":"Tahir","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5066-9892","authenticated-orcid":false,"given":"Muhammad Umer","family":"Suleman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1247-2660","authenticated-orcid":false,"given":"Syeda Nafisa","family":"Tabassum","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Bangladesh Rural Advancement Committee University Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3835-348X","authenticated-orcid":false,"given":"Umer","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ayub Medical College, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","first-page":"987\u201396","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-20260801","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/carcin\/bgp010","article-title":"Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid","volume":"30","author":"Al-Wadei","journal-title":"Carcinogenesis"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"e0250649","DOI":"10.1371\/journal.pone.0250649","article-title":"Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells","volume":"16","author":"Williford","year":"2021","journal-title":"PLOS ONE"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"275\u201379","DOI":"10.1007\/s10059-011-0027-5","article-title":"Caffeine inhibits cell proliferation and regulates PKA\/GSK3\u03b2 pathways in U87MG human glioma cells","volume":"31","author":"Ku","year":"2011","journal-title":"Mol Cells"},{"key":"R5-20260801","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/cancers12113232","article-title":"Dopamine D1 receptor in cancer","volume":"12","author":"Sobczuk","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"1982\u201393","DOI":"10.1523\/JNEUROSCI.1589-18.2018","article-title":"Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma","volume":"39","author":"Caragher","year":"2019","journal-title":"J Neurosci"},{"key":"R7-20260801","doi-asserted-by":"crossref","first-page":"1173\u201383","DOI":"10.1158\/0008-5472.CAN-09-2886","article-title":"Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival","volume":"70","author":"Kang","year":"2010","journal-title":"Cancer Res"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/ph12030130","article-title":"Methylxanthines: potential therapeutic agents for glioblastoma","volume":"12","author":"P\u00e9rez-P\u00e9rez","year":"2019","journal-title":"Pharmaceuticals"},{"key":"R9-20260801","doi-asserted-by":"crossref","first-page":"e01301","DOI":"10.1128\/msystems.01301-23","article-title":"Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer","volume":"9","author":"Mai","year":"2024","journal-title":"mSystems"},{"key":"R10-20260801","doi-asserted-by":"crossref","first-page":"1067\u201379","DOI":"10.1111\/j.1471-4159.2007.05196.x","article-title":"An update on the mechanisms of the psychostimulant effects of caffeine","volume":"105","author":"Ferr\u00e9","year":"2008","journal-title":"J Neurochem"},{"key":"R11-20260801","doi-asserted-by":"crossref","first-page":"39\u201347","DOI":"10.1158\/1055-9965.EPI-09-0732","article-title":"Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies","volume":"19","author":"Holick","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:12:21Z","timestamp":1785579141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000003853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003853","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"2025-06-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}